Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso) Professor of Medicine and Vice Chair for Research for the Department of Internal Medicine Jerzy Sarosiek, M.D., Ph.D., Dr.h.c., was recently invited to the 14th Annual Congress of International Drug Discovery Science and Technology (IDDST) conference in Seoul, South Korea. Dr. Sarosiek, who is also the medicine research laboratory director, presented a lecture based on his research of a new chloride channel CLC-2 stimulator, Lubiprostone, to restore mucus, viscosity and lubrication in patients suffering from chronic constipation — a culmination of 20 years of published works.
The annual conference serves as a platform for academics and private researchers alike to share innovations and discoveries in drug research. Topics highlighted at this year’s conference included small molecule drug design, nanotechnologies for biotherapeutic drug delivery and developments in drug delivery medical devices.
“This was a tremendous opportunity,” says Dr. Sarosiek. “Not only to present my own work, but to explore the breaking research within innovative drug discovery science technology. I’ll be able to utilize much of what I learned in my own research at TTUHSC El Paso.”
In total, the IDDST has attracted more than 50,000 researchers and professionals from 35 countries and areas to its conferences. The annual event is instrumental in connecting scientific, technological and business resources within the field of drug discovery.